Catheter Precision (VTAK) Cash from Financing Activities (2017 - 2026)

Catheter Precision (VTAK) has reported Cash from Financing Activities for 10 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 6057.33% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $9.9 million (up 13.89% YoY), while the FY2025 annual figure was $5.3 million, down 38.19% from the prior year.
• Cash from Financing Activities advanced to $4.5 million in Q1 2026 per VTAK's latest filing, from $307000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $11.2 million in Q1 2022 and bottomed at -$516000.0 in Q2 2022.
• Historically, Cash from Financing Activities has averaged $3.1 million across 5 years, with a median of $2.6 million in 2025.
• On a YoY basis, Cash from Financing Activities climbed as much as 6956.44% in 2022 and fell as far as 104.81% in 2022.
• Catheter Precision's Cash from Financing Activities stood at $5.2 million in 2022, then tumbled by 102.06% to -$107000.0 in 2023, then jumped by 4276.64% to $4.5 million in 2024, then tumbled by 93.13% to $307000.0 in 2025, then surged by 1355.37% to $4.5 million in 2026.
• Business Quant data shows VTAK's Cash from Financing Activities at $4.5 million in Q1 2026, $307000.0 in Q4 2025, and $2.4 million in Q3 2025.